179 related articles for article (PubMed ID: 21953546)
21. Choline phospholipid metabolism: a target in cancer cells?
Ackerstaff E; Glunde K; Bhujwalla ZM
J Cell Biochem; 2003 Oct; 90(3):525-33. PubMed ID: 14523987
[TBL] [Abstract][Full Text] [Related]
22. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
Glunde K; Ackerstaff E; Mori N; Jacobs MA; Bhujwalla ZM
Mol Pharm; 2006; 3(5):496-506. PubMed ID: 17009848
[TBL] [Abstract][Full Text] [Related]
23. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
24. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
Beloueche-Babari M; Arunan V; Troy H; te Poele RH; te Fong AC; Jackson LE; Payne GS; Griffiths JR; Judson IR; Workman P; Leach MO; Chung YL
Cancer Res; 2012 Feb; 72(4):990-1000. PubMed ID: 22194463
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
Pan MR; Hou MF; Chang HC; Hung WC
J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts.
Krishnamachary B; Stasinopoulos I; Kakkad S; Penet MF; Jacob D; Wildes F; Mironchik Y; Pathak AP; Solaiyappan M; Bhujwalla ZM
Oncotarget; 2017 Mar; 8(11):17981-17994. PubMed ID: 28152501
[TBL] [Abstract][Full Text] [Related]
28. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
[TBL] [Abstract][Full Text] [Related]
29. The malignant phenotype of breast cancer cells is reduced by COX-2 silencing.
Stasinopoulos I; Mori N; Bhujwalla ZM
Neoplasia; 2008 Nov; 10(11):1163-9. PubMed ID: 18953425
[TBL] [Abstract][Full Text] [Related]
30. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies.
Eliyahu G; Kreizman T; Degani H
Int J Cancer; 2007 Apr; 120(8):1721-30. PubMed ID: 17236204
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
Glunde K; Jie C; Bhujwalla ZM
Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
[TBL] [Abstract][Full Text] [Related]
32. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.
Kang JH; Song KH; Jeong KC; Kim S; Choi C; Lee CH; Oh SH
BMC Cancer; 2011 Aug; 11():334. PubMed ID: 21813027
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
Teichert F; Verschoyle RD; Greaves P; Edwards RE; Teahan O; Jones DJ; Wilson ID; Farmer PB; Steward WP; Gant TW; Gescher AJ; Keun HC
Prostate; 2008 Jul; 68(10):1035-47. PubMed ID: 18459103
[TBL] [Abstract][Full Text] [Related]
36. COX-2 dependent regulation of mechanotransduction in human breast cancer cells.
Yoon AR; Stasinopoulos I; Kim JH; Yong HM; Kilic O; Wirtz D; Bhujwalla ZM; An SS
Cancer Biol Ther; 2015; 16(3):430-7. PubMed ID: 25701047
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
[TBL] [Abstract][Full Text] [Related]
38. Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline.
Mori N; Delsite R; Natarajan K; Kulawiec M; Bhujwalla ZM; Singh KK
Mol Imaging; 2004 Oct; 3(4):319-23. PubMed ID: 15802048
[TBL] [Abstract][Full Text] [Related]
39. Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2.
Allison SE; Petrovic N; Mackenzie PI; Murray M
Biochem Pharmacol; 2015 Aug; 96(4):306-14. PubMed ID: 26067757
[TBL] [Abstract][Full Text] [Related]
40. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
Huang C; Hydo LM; Liu S; Miller RT
Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
